LicianPro

TNBI stock

Tanke Biosciences Corporation (TNBI) financials · rev $28.6M

Compare AAPL vs MSFT

Tanke Biosciences Corporation (TNBI) rev $28.6M.

Annual income statement
LineFY2012FY2011Pro (2 older periods with Lician Pro)
Revenue$28.56M$23.83M
Cost of Revenue$18.62M$15.06M
Gross Profit$9.94M$8.77M
Operating Income$4.53M$1.74M
Net Income−$210.25K−$3.14M
EPS (Diluted)—−$0.24
Unlock 4 years of statements: Lician Pro $149/yr
Annual balance sheet
LineFY2012FY2011Pro (2 older periods with Lician Pro)
Total Assets$28.85M$24.89M
Current Assets—$18.91M
Cash & Equivalents$6.17M$7.70M
Inventory—$1.19M
PP&E—$4.77M
Total Liabilities$12.93M$9.03M
Current Liabilities—$3.55M
Short-term Debt—$785.46K
Long-term Debt—$628.37K
Total Debt—$1.41M
Shareholders' Equity—$15.85M
Retained Earnings—$2.70M

† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).

Annual cash flow
LineFY2012FY2011Pro (1 older periods with Lician Pro)
Investing Cash Flow−$1.53M−$3.56M
Financing Cash Flow$1.12M$5.82M

Source: Company filings with the SEC (EDGAR) · Latest period FY2012

These statements as JSON? API free 100/day

FAQ

What is TNBI P/E and revenue?

Tanke Biosciences Corporation (TNBI) rev $28.6M.

What is TNBI revenue?

Tanke Biosciences Corporation last cached revenue is $28.6M (FY2012).

Is TNBI profitable?

Tanke Biosciences Corporation last cached net income is -$210.2K (FY2012).

What are TNBI total assets?

Tanke Biosciences Corporation last cached total assets are $28.8M (FY2012).

What is TNBI free cash flow?

No cached cash-flow row for TNBI yet.

Not investment advice. Figures as reported in company filings, not a live feed.